लोड हो रहा है...
Dornase alfa for cystic fibrosis
BACKGROUND: Dornase alfa is currently used as a mucolytic to treat pulmonary disease (the major cause of morbidity and mortality) in cystic fibrosis. It reduces mucus viscosity in the lungs, promoting improved clearance of secretions. This is an update of a previously published review. OBJECTIVES: T...
में बचाया:
| में प्रकाशित: | Cochrane Database Syst Rev |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
John Wiley & Sons, Ltd
2018
|
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513278/ https://ncbi.nlm.nih.gov/pubmed/30187450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001127.pub4 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|